Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 Sep;22(3):353–357. doi: 10.1128/aac.22.3.353

Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination.

D Adam, I de Visser, P Koeppe
PMCID: PMC183747  PMID: 7137979

Abstract

The pharmacokinetics of amoxicillin and clavulanic acid, administered alone and in combination, were studied in six male and six female normal human volunteers. Each ingested 500 mg of amoxicillin or 125 mg of clavulanic acid or the above agents in combination in randomized sequences. The results indicate that most of the parameters tested for either substance are essentially independent of the presence of the other one.

Full text

PDF
353

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ball P., Watson T., Mehtar S. Amoxycillin and clavulanic acid in intra-abdominal and pelvic sepsis. J Antimicrob Chemother. 1981 Apr;7(4):441–444. doi: 10.1093/jac/7.4.441. [DOI] [PubMed] [Google Scholar]
  2. Bennett J. V., Brodie J. L., Benner E. J., Kirby W. M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966 Mar;14(2):170–177. doi: 10.1128/am.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dalhoff A., Koeppe P., von Kobyletzki D. Untersuchungen zur Pharmakokinetik von Amoxicillin nach intravenöser, intramuskulärer und oraler Applikation. Arzneimittelforschung. 1981;31(7):1148–1157. [PubMed] [Google Scholar]
  4. Koeppe P., Hamann C. A program for non-linear regression analysis to be used on desk-top computers. Comput Programs Biomed. 1980 Dec;12(2-3):121–128. doi: 10.1016/0010-468x(80)90058-6. [DOI] [PubMed] [Google Scholar]
  5. Leigh D. A., Bradnock K., Marriner J. M. Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria. J Antimicrob Chemother. 1981 Mar;7(3):229–236. doi: 10.1093/jac/7.3.229. [DOI] [PubMed] [Google Scholar]
  6. Matsuura M., Nakazawa H., Hashimoto T., Mitsuhashi S. Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains. Antimicrob Agents Chemother. 1980 Jun;17(6):908–911. doi: 10.1128/aac.17.6.908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Matthew M. Plasmid-mediated beta-lactamases of Gram-negative bacteria: properties and distribution. J Antimicrob Chemother. 1979 Jul;5(4):349–358. doi: 10.1093/jac/5.4.349. [DOI] [PubMed] [Google Scholar]
  8. Münch R., Lüthy R., Blaser J., Siegenthaler W. Human pharmacokinetics and CSF penetration of clavulanic acid. J Antimicrob Chemother. 1981 Jul;8(1):29–37. doi: 10.1093/jac/8.1.29. [DOI] [PubMed] [Google Scholar]
  9. Neu H. C., Fu K. P. Clavulanic acid, a novel inhibitor of beta-lactamases. Antimicrob Agents Chemother. 1978 Nov;14(5):650–655. doi: 10.1128/aac.14.5.650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Peters G., Pulverer G., Neugebauer M. In vitro-activity of clavulanic acid and amoxicillin combined against amoxicillin-resistant bacteria. Infection. 1980;8(3):104–106. doi: 10.1007/BF01641472. [DOI] [PubMed] [Google Scholar]
  11. Reading C., Cole M. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother. 1977 May;11(5):852–857. doi: 10.1128/aac.11.5.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Reading C., Hepburn P. The inhibition of staphylococcal beta-lactamase by clavulanic acid. Biochem J. 1979 Apr 1;179(1):67–76. doi: 10.1042/bj1790067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Van Landuyt H. W., Pyckavet M., Lambert A. M. Comparative activity of BRL 25.000 with amoxycillin against resistant clinical isolates. J Antimicrob Chemother. 1981 Jan;7(1):65–70. doi: 10.1093/jac/7.1.65. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES